|
NL154600B
(nl)
|
1971-02-10 |
1977-09-15 |
Organon Nv |
Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
|
|
US3949064A
(en)
|
1973-10-26 |
1976-04-06 |
Baxter Laboratories, Inc. |
Method of detecting antigens or antibodies
|
|
GB1499035A
(en)
|
1975-04-10 |
1978-01-25 |
Ts Nii Gematologii I Perelivan |
Antistaphylococcus human immune globulin and method of preparing same
|
|
US4174384A
(en)
|
1975-06-30 |
1979-11-13 |
Syva Company |
Fluorescence quenching with immunological pairs in immunoassays
|
|
US4367110A
(en)
|
1979-07-02 |
1983-01-04 |
Toppan Printing Co. |
Decorative laminate and a manufacturing method therefor
|
|
US4327082A
(en)
|
1979-07-12 |
1982-04-27 |
Adcock-Ingram Laboratories Limited |
Mastitis vaccination
|
|
US4372945A
(en)
|
1979-11-13 |
1983-02-08 |
Likhite Vilas V |
Antigen compounds
|
|
US4452901A
(en)
|
1980-03-20 |
1984-06-05 |
Ciba-Geigy Corporation |
Electrophoretically transferring electropherograms to nitrocellulose sheets for immuno-assays
|
|
US4338298A
(en)
|
1980-04-04 |
1982-07-06 |
Endowment And Research Foundation At Montana State University |
Vaccine for passive immunization against enteric colibacillosis and method of use
|
|
US4554101A
(en)
|
1981-01-09 |
1985-11-19 |
New York Blood Center, Inc. |
Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
|
|
IL61904A
(en)
|
1981-01-13 |
1985-07-31 |
Yeda Res & Dev |
Synthetic vaccine against influenza virus infections comprising a synthetic peptide and process for producing same
|
|
US4356170A
(en)
|
1981-05-27 |
1982-10-26 |
Canadian Patents & Development Ltd. |
Immunogenic polysaccharide-protein conjugates
|
|
US4596792A
(en)
|
1981-09-04 |
1986-06-24 |
The Regents Of The University Of California |
Safe vaccine for hepatitis containing polymerized serum albumin
|
|
NL8200523A
(nl)
|
1982-02-11 |
1983-09-01 |
Univ Leiden |
Werkwijze voor het in vitro transformeren van planteprotoplasten met plasmide-dna.
|
|
US4748018A
(en)
|
1984-02-07 |
1988-05-31 |
Stolle Research & Development Corp. |
Method of passive immunization of mammals using avian antibody
|
|
JPS5938877A
(ja)
|
1982-08-30 |
1984-03-02 |
Musashi Eng Kk |
紙葉判別方法
|
|
US5151350A
(en)
|
1982-10-27 |
1992-09-29 |
Repligen Corporation |
Cloned genes encoding recombinant protein a
|
|
US4599230A
(en)
|
1984-03-09 |
1986-07-08 |
Scripps Clinic And Research Foundation |
Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
|
|
US4599231A
(en)
|
1984-03-09 |
1986-07-08 |
Scripps Clinic And Research Foundation |
Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
|
|
US4879236A
(en)
|
1984-05-16 |
1989-11-07 |
The Texas A&M University System |
Method for producing a recombinant baculovirus expression vector
|
|
US5189015A
(en)
|
1984-05-30 |
1993-02-23 |
Alfa-Laval Agri International Ab |
Method for prophylactic treatment of the colonization of a Staphylococcus aureus bacterial strain by bacterial cell surface protein with fibronectin and fibrinogen binding ability
|
|
US5310687A
(en)
|
1984-10-31 |
1994-05-10 |
Igen, Inc. |
Luminescent metal chelate labels and means for detection
|
|
US5221605A
(en)
|
1984-10-31 |
1993-06-22 |
Igen, Inc. |
Luminescent metal chelate labels and means for detection
|
|
US5238808A
(en)
|
1984-10-31 |
1993-08-24 |
Igen, Inc. |
Luminescent metal chelate labels and means for detection
|
|
US4608251A
(en)
|
1984-11-09 |
1986-08-26 |
Pitman-Moore, Inc. |
LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
US4601903A
(en)
|
1985-05-01 |
1986-07-22 |
The United States Of America As Represented By The Department Of Health And Human Services |
Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease
|
|
US4690915A
(en)
|
1985-08-08 |
1987-09-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adoptive immunotherapy as a treatment modality in humans
|
|
US4800159A
(en)
|
1986-02-07 |
1989-01-24 |
Cetus Corporation |
Process for amplifying, detecting, and/or cloning nucleic acid sequences
|
|
US5084269A
(en)
|
1986-11-06 |
1992-01-28 |
Kullenberg Fred W |
Adjuvant for dose treatment with antigens
|
|
AU622104B2
(en)
|
1987-03-11 |
1992-04-02 |
Sangtec Molecular Diagnostics Ab |
Method of assaying of nucleic acids, a reagent combination and kit therefore
|
|
US5320951A
(en)
|
1987-06-01 |
1994-06-14 |
Hoeoek Magnus |
Fibronectin binding protein as well as its preparation
|
|
FR2619122B1
(fr)
|
1987-08-03 |
1990-03-09 |
Pasteur Institut |
Procede d'obtention de polyosides capsulaires de staphylocoques, polyosides obtenus, applications de ces polyosides et souches pour la mise en oeuvre du procede
|
|
US4952500A
(en)
|
1988-02-01 |
1990-08-28 |
University Of Georgia Research Foundation, Inc. |
Cloning systems for Rhodococcus and related bacteria
|
|
US5258494A
(en)
*
|
1988-04-08 |
1993-11-02 |
Stryker Corporation |
Osteogenic proteins
|
|
US5858652A
(en)
|
1988-08-30 |
1999-01-12 |
Abbott Laboratories |
Detection and amplification of target nucleic acid sequences
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
SE8901687D0
(sv)
|
1989-05-11 |
1989-05-11 |
Alfa Laval Agri Int |
Fibronectin binding protein as well as its preparation
|
|
US5302523A
(en)
|
1989-06-21 |
1994-04-12 |
Zeneca Limited |
Transformation of plant cells
|
|
US5550318A
(en)
|
1990-04-17 |
1996-08-27 |
Dekalb Genetics Corporation |
Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof
|
|
US7705215B1
(en)
|
1990-04-17 |
2010-04-27 |
Dekalb Genetics Corporation |
Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof
|
|
US5322783A
(en)
|
1989-10-17 |
1994-06-21 |
Pioneer Hi-Bred International, Inc. |
Soybean transformation by microparticle bombardment
|
|
US5484956A
(en)
|
1990-01-22 |
1996-01-16 |
Dekalb Genetics Corporation |
Fertile transgenic Zea mays plant comprising heterologous DNA encoding Bacillus thuringiensis endotoxin
|
|
SE466259B
(sv)
|
1990-05-31 |
1992-01-20 |
Arne Forsgren |
Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
|
|
US5384253A
(en)
|
1990-12-28 |
1995-01-24 |
Dekalb Genetics Corporation |
Genetic transformation of maize cells by electroporation of cells pretreated with pectin degrading enzymes
|
|
CA2059693C
(en)
|
1991-01-28 |
2003-08-19 |
Peter J. Kniskern |
Polysaccharide antigens from streptococcus pneumoniae
|
|
CA2059692C
(en)
|
1991-01-28 |
2004-11-16 |
Peter J. Kniskern |
Pneumoccoccal polysaccharide conjugate vaccine
|
|
US5199942A
(en)
|
1991-06-07 |
1993-04-06 |
Immunex Corporation |
Method for improving autologous transplantation
|
|
WO1993004169A1
(en)
|
1991-08-20 |
1993-03-04 |
Genpharm International, Inc. |
Gene targeting in animal cells using isogenic dna constructs
|
|
US5610042A
(en)
|
1991-10-07 |
1997-03-11 |
Ciba-Geigy Corporation |
Methods for stable transformation of wheat
|
|
US5620896A
(en)
|
1992-03-23 |
1997-04-15 |
University Of Massachusetts Medical Center |
DNA vaccines against rotavirus infections
|
|
NZ251621A
(en)
|
1992-03-26 |
1996-04-26 |
Microcarb Inc |
Polyclonal antibodies to shiga-like toxins
|
|
DE69334225D1
(de)
|
1992-07-07 |
2008-07-31 |
Japan Tobacco Inc |
Verfahren zur transformation einer monokotyledon pflanze
|
|
US5702932A
(en)
|
1992-07-20 |
1997-12-30 |
University Of Florida |
Microinjection methods to transform arthropods with exogenous DNA
|
|
EP0652965A1
(en)
|
1992-07-27 |
1995-05-17 |
Pioneer Hi-Bred International, Inc. |
An improved method of agrobacterium-mediated transformation of cultured soybean cells
|
|
DE4228457A1
(de)
|
1992-08-27 |
1994-04-28 |
Beiersdorf Ag |
Herstellung von heterodimerem PDGF-AB mit Hilfe eines bicistronischen Vektorsystems in Säugerzellen
|
|
EP0621875B1
(en)
|
1992-09-21 |
2002-03-27 |
Alfa-Laval Agri International Ab |
Fibrinogen binding protein
|
|
GB9222888D0
(en)
|
1992-10-30 |
1992-12-16 |
British Tech Group |
Tomography
|
|
US5846709A
(en)
|
1993-06-15 |
1998-12-08 |
Imclone Systems Incorporated |
Chemical process for amplifying and detecting nucleic acid sequences
|
|
FR2708288B1
(fr)
|
1993-07-26 |
1995-09-01 |
Bio Merieux |
Procédé d'amplification d'acides nucléiques par transcription utilisant le déplacement, réactifs et nécessaire pour la mise en Óoeuvre de ce procédé.
|
|
ATE254475T1
(de)
|
1993-09-22 |
2003-12-15 |
Jackson H M Found Military Med |
Verfahren zur aktivierung von löslichem kohlenhydraten durch verwendung von neuen cyanylierungsreagenzien, zur herstellung von immunogenischen konstrukten
|
|
US5928905A
(en)
|
1995-04-18 |
1999-07-27 |
Glaxo Group Limited |
End-complementary polymerase reaction
|
|
US5648240A
(en)
|
1994-05-24 |
1997-07-15 |
Texas A&M University |
MHC II analog from Staphylococcus aureus
|
|
WO1995033073A1
(en)
|
1994-05-28 |
1995-12-07 |
Tepnel Medical Limited |
Producing copies of nucleic acids
|
|
US5656610A
(en)
|
1994-06-21 |
1997-08-12 |
University Of Southern California |
Producing a protein in a mammal by injection of a DNA-sequence into the tongue
|
|
US5942391A
(en)
|
1994-06-22 |
1999-08-24 |
Mount Sinai School Of Medicine |
Nucleic acid amplification method: ramification-extension amplification method (RAM)
|
|
FR2722208B1
(fr)
|
1994-07-05 |
1996-10-04 |
Inst Nat Sante Rech Med |
Nouveau site interne d'entree des ribosomes, vecteur le contenant et utilisation therapeutique
|
|
US6008341A
(en)
|
1994-08-22 |
1999-12-28 |
The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin |
S. aureus fibrinogen binding protein gene
|
|
US5871986A
(en)
|
1994-09-23 |
1999-02-16 |
The General Hospital Corporation |
Use of a baculovirus to express and exogenous gene in a mammalian cell
|
|
US5736524A
(en)
|
1994-11-14 |
1998-04-07 |
Merck & Co.,. Inc. |
Polynucleotide tuberculosis vaccine
|
|
US5935825A
(en)
|
1994-11-18 |
1999-08-10 |
Shimadzu Corporation |
Process and reagent for amplifying nucleic acid sequences
|
|
US6770278B1
(en)
|
1994-12-02 |
2004-08-03 |
Central Biomedia, Inc. |
Methods of making and using immunoglobulin (Ig) compositions
|
|
US5548066A
(en)
|
1994-12-02 |
1996-08-20 |
Central Biomedia, Inc. |
Failure of passive transfer immune serum and method of making same
|
|
US5843650A
(en)
|
1995-05-01 |
1998-12-01 |
Segev; David |
Nucleic acid detection and amplification by chemical linkage of oligonucleotides
|
|
JPH11514870A
(ja)
|
1995-10-16 |
1999-12-21 |
スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー |
新規な唾液結合タンパク質
|
|
US5780448A
(en)
|
1995-11-07 |
1998-07-14 |
Ottawa Civic Hospital Loeb Research |
DNA-based vaccination of fish
|
|
US6833253B2
(en)
|
1996-01-05 |
2004-12-21 |
Human Genome Sciences, Inc. |
Staphylococcus aureus polynucleotides and polypeptides
|
|
US6737248B2
(en)
|
1996-01-05 |
2004-05-18 |
Human Genome Sciences, Inc. |
Staphylococcus aureus polynucleotides and sequences
|
|
US5612473A
(en)
|
1996-01-16 |
1997-03-18 |
Gull Laboratories |
Methods, kits and solutions for preparing sample material for nucleic acid amplification
|
|
FR2746398B1
(fr)
|
1996-03-21 |
1998-04-30 |
Bio Merieux |
Anticorps specifique de staphylococcus aureaus, et utilisations
|
|
US5928906A
(en)
|
1996-05-09 |
1999-07-27 |
Sequenom, Inc. |
Process for direct sequencing during template amplification
|
|
WO1997043314A2
(en)
|
1996-05-16 |
1997-11-20 |
The Texas A & M University System |
Collagen binding protein compositions and methods of use
|
|
US6013763A
(en)
|
1996-06-04 |
2000-01-11 |
Genentech, Inc. |
Peptide variants of protein A
|
|
US5939291A
(en)
|
1996-06-14 |
1999-08-17 |
Sarnoff Corporation |
Microfluidic method for nucleic acid amplification
|
|
US5945100A
(en)
|
1996-07-31 |
1999-08-31 |
Fbp Corporation |
Tumor delivery vehicles
|
|
US6294177B1
(en)
|
1996-09-11 |
2001-09-25 |
Nabi |
Staphylococcus aureus antigen-containing whole cell vaccine
|
|
US5849546A
(en)
|
1996-09-13 |
1998-12-15 |
Epicentre Technologies Corporation |
Methods for using mutant RNA polymerases with reduced discrimination between non-canonical and canonical nucleoside triphosphates
|
|
US5981274A
(en)
|
1996-09-18 |
1999-11-09 |
Tyrrell; D. Lorne J. |
Recombinant hepatitis virus vectors
|
|
JP2002514056A
(ja)
|
1996-10-23 |
2002-05-14 |
アメリカン・ホーム・プロダクツ・コーポレーション |
ワクチン
|
|
US5849497A
(en)
|
1997-04-03 |
1998-12-15 |
The Research Foundation Of State University Of New York |
Specific inhibition of the polymerase chain reaction using a non-extendable oligonucleotide blocker
|
|
US6610293B1
(en)
|
1997-06-16 |
2003-08-26 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
|
|
US5866366A
(en)
|
1997-07-01 |
1999-02-02 |
Smithkline Beecham Corporation |
gidB
|
|
US5916776A
(en)
|
1997-08-27 |
1999-06-29 |
Sarnoff Corporation |
Amplification method for a polynucleotide
|
|
US6756361B1
(en)
|
1997-10-14 |
2004-06-29 |
Nabi |
Enterococcus antigens and vaccines
|
|
US5994624A
(en)
|
1997-10-20 |
1999-11-30 |
Cotton Incorporated |
In planta method for the production of transgenic plants
|
|
US5932451A
(en)
|
1997-11-19 |
1999-08-03 |
Incyte Pharmaceuticals, Inc. |
Method for unbiased mRNA amplification
|
|
US6680195B1
(en)
|
1997-11-26 |
2004-01-20 |
Inhibitex, Inc. |
Extracellular matrix-binding proteins from staphylococcus aureus
|
|
AU1537699A
(en)
|
1997-11-26 |
1999-06-15 |
Bioresearch Ireland a division of Eolas - The Irish Science and Technology Agency |
Extracellular matrix-binding proteins from (staphylococcus aureus)
|
|
AU758019B2
(en)
|
1998-07-10 |
2003-03-13 |
U.S. Medical Research Institute Of Infectious Diseases |
Anthrax vaccine
|
|
US6703025B1
(en)
|
1998-08-31 |
2004-03-09 |
Inhibitex, Inc. |
Multicomponent vaccines
|
|
US6635473B1
(en)
|
1998-08-31 |
2003-10-21 |
The Provost Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin |
Polypeptides and polynucleotides from coagulase-negative staphylococci
|
|
WO2000012131A1
(en)
|
1998-08-31 |
2000-03-09 |
Inhibitex, Inc. |
Multicomponent vaccines
|
|
US6692739B1
(en)
|
1998-08-31 |
2004-02-17 |
Inhibitex, Inc. |
Staphylococcal immunotherapeutics via donor selection and donor stimulation
|
|
CA2341177A1
(en)
|
1998-08-31 |
2000-03-09 |
Inhibitex, Inc. |
Staphylococcal immunotherapeutics via donor selection and donor stimulation
|
|
EP1109911A4
(en)
|
1998-09-01 |
2005-04-27 |
Human Genome Sciences Inc |
STAPHYLOCOCCUS AUREUS GENES AND ASSOCIATED POLYPEPTIDES
|
|
DK1121135T3
(da)
|
1998-09-14 |
2009-03-23 |
Nabi Biopharmaceuticals |
Præparater af beta-glucaner og specifikke immunglobuliner
|
|
AU769539B2
(en)
|
1999-01-29 |
2004-01-29 |
Zoetis Services Llc |
Adjuvants for use in vaccines
|
|
US6936258B1
(en)
|
1999-03-19 |
2005-08-30 |
Nabi Biopharmaceuticals |
Staphylococcus antigen and vaccine
|
|
WO2000064925A1
(en)
|
1999-04-28 |
2000-11-02 |
The Provost Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin |
Method of inhibiting leukocyte adhesion to fibrinogen
|
|
JP2003503015A
(ja)
|
1999-05-03 |
2003-01-28 |
メダレツクス・インコーポレーテツド |
スタフィロコッカス・アウレウスに対するヒト抗体
|
|
WO2000069457A1
(en)
|
1999-05-15 |
2000-11-23 |
University Of California, San Diego |
Protein a based binding domains with desirable activities
|
|
WO2001034809A2
(en)
|
1999-11-09 |
2001-05-17 |
Glaxo Group Limited |
Staphylococcus epidermidis nucleic acids and proteins
|
|
EP1196193B1
(en)
|
1999-12-03 |
2008-11-05 |
Celltech Chiroscience Limited |
Interleukin-1 mutein useful as vaccine adjuvant
|
|
US6651655B1
(en)
|
2000-01-18 |
2003-11-25 |
Quadrant Technologies Limited |
Inhaled vaccines
|
|
SE0000514D0
(sv)
|
2000-02-17 |
2000-02-17 |
Biostapro Ab |
A 52 kDa protein from coagulase negative staphylococci and fragments
|
|
WO2001070267A1
(en)
|
2000-03-17 |
2001-09-27 |
Inhibitex, Inc. |
Cross-reactive displacing antibodies from collagen-binding proteins and method of identification and use
|
|
EP1268774A2
(en)
|
2000-03-21 |
2003-01-02 |
Elitra Pharmaceuticals, Inc. |
Identification of essential genes in prokaryotes
|
|
GB0014907D0
(en)
|
2000-06-20 |
2000-08-09 |
Univ Sheffield |
Antigenic polypeptides
|
|
SE0003573D0
(sv)
|
2000-10-04 |
2000-10-04 |
Bengt Guss |
Method and means for producing novel von Willebrand factor binding proteins and their use in biotechnology
|
|
AU1486102A
(en)
|
2000-11-07 |
2002-05-21 |
Immunovaccine Technologies Inc |
Vaccines with enhanced immune response and methods for their preparation
|
|
AT410798B
(de)
|
2001-01-26 |
2003-07-25 |
Cistem Biotechnologies Gmbh |
Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
|
|
WO2002074324A1
(en)
|
2001-03-15 |
2002-09-26 |
The Texas A & M University System |
Collagen-binding adhesin from staphylococcus epidermidis and method of use
|
|
GB0107661D0
(en)
*
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
|
AU2002309650A1
(en)
|
2001-05-08 |
2002-11-18 |
The Texas A And M University System |
Highly conserved proteins from gram-positive bacteria
|
|
EP2320233A1
(en)
|
2001-06-15 |
2011-05-11 |
Inhibitex, Inc. |
Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
|
|
CA2351018A1
(en)
|
2001-07-09 |
2003-01-09 |
Universite De Sherbrooke |
Dna vaccine against staphylococcus aureus
|
|
CA2808598A1
(en)
|
2001-08-02 |
2003-02-13 |
University Of Sheffield |
Antigenic polypeptides
|
|
US20030113350A1
(en)
|
2001-09-19 |
2003-06-19 |
Fattom Ali I. |
Glycoconjugate vaccines for use in immune-compromised populations
|
|
US7115264B2
(en)
|
2001-11-05 |
2006-10-03 |
Inhibitex |
Monoclonal antibodies to the fibronectin binding protein and method of use in treating or preventing infections
|
|
WO2003041726A1
(en)
|
2001-11-16 |
2003-05-22 |
Biostapro Ab |
Use of an extracellular adherence protein for the manufacture of an anti-inflammatory drug
|
|
WO2003053462A2
(en)
|
2001-12-11 |
2003-07-03 |
Merck & Co., Inc. |
Staphylococcus aureus exopolysaccharide and process
|
|
CA2478029A1
(en)
|
2002-03-05 |
2003-09-18 |
Inhibitex, Inc. |
Monoclonal and polyclonal antibodies recognizing coagulase-negative staphylococcal proteins
|
|
US7736652B2
(en)
|
2002-03-21 |
2010-06-15 |
The Regents Of The University Of California |
Antibody fusion proteins: effective adjuvants of protein vaccination
|
|
US6984381B2
(en)
|
2002-07-05 |
2006-01-10 |
The United States Of America As Represented By The Secretary Of Agriculture |
Vaccine for the prevention of bacterial infection of the bovine mammary gland
|
|
WO2004025416A2
(en)
|
2002-09-13 |
2004-03-25 |
The Texas A & M University System |
Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby
|
|
US20050220788A1
(en)
|
2002-10-03 |
2005-10-06 |
Intercell Ag |
Use of molecules which interact with the haptoglobin receptor ligand binding
|
|
US7723087B2
(en)
|
2002-11-12 |
2010-05-25 |
The Brigham And Women's Hospital, Inc. |
Nucleic acid molecules for enhanced production of a bacterial polysaccharide and methods of use thereof
|
|
US10919956B2
(en)
|
2002-11-12 |
2021-02-16 |
The Brigham And Women's Hospital, Inc. |
Polysaccharide vaccine for staphylococcal infections
|
|
EP1580557A4
(en)
*
|
2002-11-22 |
2006-09-06 |
Daiichi Pure Chemicals Co Ltd |
METHOD FOR THE STUDY OF STAPHYLOCOCCUS AUREUS
|
|
EP1611155A2
(en)
|
2003-03-28 |
2006-01-04 |
Elusys Therapeutics, Inc. |
Method and compositions for conversion of antibody activity
|
|
US20070053925A1
(en)
|
2003-04-16 |
2007-03-08 |
Eric Brown |
Staphylococcus aureus efb protein and c3 binding region which inhibit complement activation
|
|
US20060188515A1
(en)
|
2003-07-24 |
2006-08-24 |
Anderson Annaliesa S |
Polypeptides for inducing a protective immune response against staphylococcus aureus
|
|
NZ544542A
(en)
|
2003-07-24 |
2009-01-31 |
Merck & Co Inc |
Polypeptides for inducing a protective immune response against staphylococcus aureus
|
|
US20080160089A1
(en)
|
2003-10-14 |
2008-07-03 |
Medivas, Llc |
Vaccine delivery compositions and methods of use
|
|
CA2555342A1
(en)
|
2004-02-18 |
2005-09-01 |
Merck & Co., Inc. |
Polypeptides for inducing a protective immune response against staphylococcus aureus
|
|
EP1791560A4
(en)
|
2004-09-17 |
2009-01-14 |
Merck & Co Inc |
POLYPEPTIDES FOR INDUCING A PROTECTIVE IMMUNE RESPONSE AGAINST STAPHYLOCOCCUS AUREUS
|
|
ES2730275T3
(es)
|
2004-09-22 |
2019-11-11 |
Glaxosmithkline Biologicals Sa |
Composición inmunógena para uso en vacunación contra estafilococos
|
|
CA2581746A1
(en)
|
2004-10-25 |
2006-06-08 |
The University Of Western Ontario |
Staphylococcus aureus isd protein-based anti-infectives
|
|
EP1814918A1
(en)
|
2004-10-29 |
2007-08-08 |
Elusys Therapeutics, Inc. |
Use of cr1-binding molecules in clearance and induction of immune responses
|
|
US20060134141A1
(en)
|
2004-12-14 |
2006-06-22 |
Nabi Biopharmaceuticals |
Glycoconjugate vaccines containing peptidoglycan
|
|
EP1838341B1
(en)
|
2005-01-20 |
2013-08-14 |
Isconova AB |
Vaccine composition comprising a fibronectin binding protein or a fibronectin binding peptide
|
|
US20060228368A1
(en)
|
2005-04-07 |
2006-10-12 |
Nabi Biopharmaceuticals |
Method of protecting against staphylococcal infection
|
|
US8398991B2
(en)
|
2005-06-22 |
2013-03-19 |
Institut Pasteur |
Modified ESAT-6 molecules and improved vaccine strains of Mycobacterium bovis BCG
|
|
GB0526038D0
(en)
|
2005-12-21 |
2006-02-01 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
|
CA2637598A1
(en)
*
|
2006-01-18 |
2007-02-14 |
University Of Chicago |
Compositions and methods related to staphylococcal bacterium proteins
|
|
EP1982185A4
(en)
|
2006-01-27 |
2010-04-28 |
Merck Sharp & Dohme |
ON S. AUREUS ORF0657N OBJECTIVE ANTIGEN-BINDING PROTEINS
|
|
WO2007095057A2
(en)
|
2006-02-10 |
2007-08-23 |
Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Use of eap protein for treating and preventing autoimmune neuroinflammatory diseases
|
|
AU2007221321B2
(en)
|
2006-02-22 |
2012-06-28 |
The Texas A & M University System |
Antibodies recognizing a highly expressed putative antigen of CA-MRSA and methods of use
|
|
KR101541383B1
(ko)
|
2006-03-30 |
2015-08-03 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
면역원성 조성물
|
|
AR060188A1
(es)
|
2006-03-30 |
2008-05-28 |
Glaxosmithkline Biolog Sa |
Procedimiento de conjugacion
|
|
AU2007259415B2
(en)
|
2006-06-12 |
2013-09-26 |
Glaxosmithkline Biologicals Sa |
Use of alpha-toxin for treating and preventing Staphylococcus infections
|
|
WO2008152447A2
(en)
|
2006-10-30 |
2008-12-18 |
The University Of Western Ontario |
Staphylococcus aureus specific anti-infectives
|
|
WO2008140487A2
(en)
|
2006-11-14 |
2008-11-20 |
Elusys Therapeutics, Inc. |
Improved staphylococcal protein a mono- and bispecific antibodies and methods of their use
|
|
US7488807B2
(en)
|
2006-11-22 |
2009-02-10 |
3M Innovative Properties Company |
Antibody with protein A selectivity
|
|
US20100047252A1
(en)
|
2006-11-22 |
2010-02-25 |
3M Innovative Properties Company |
Antibody with protein a selectivity
|
|
GB0700136D0
(en)
|
2007-01-04 |
2007-02-14 |
Glaxosmithkline Biolog Sa |
Process for manufacturing vaccines
|
|
US20100166772A1
(en)
|
2007-05-31 |
2010-07-01 |
Anderson Annaliesa S |
ANTIGEN-BINDING PROTEINS TARGETING S. AUREUS ORF0657n
|
|
AU2009246510B2
(en)
|
2008-05-12 |
2014-02-13 |
Strox Biopharmaceuticals, Llc |
Staphylococcus aureus-specific antibody preparations
|
|
US8592555B2
(en)
|
2008-08-11 |
2013-11-26 |
Emd Millipore Corporation |
Immunoglobulin-binding proteins with improved specificity
|
|
AU2009329866B2
(en)
|
2008-12-23 |
2016-09-29 |
Genentech, Inc. |
Immunoglobulin variants with altered binding to protein A
|
|
SMT202000246T1
(it)
|
2009-04-03 |
2020-07-08 |
Univ Chicago |
Composizioni e metodi relativi a varianti della proteina a (spa)
|
|
SI2445522T1
(sl)
|
2009-06-22 |
2017-10-30 |
Wyeth Llc |
Imunogeni sestavki antigenov Staphylococcusa aureusa
|
|
FR2957821B1
(fr)
|
2010-03-24 |
2014-08-29 |
Inst Francais Du Petrole |
Nouvelle zone de regeneration du catalyseur divisee en secteurs pour unites catalytiques regeneratives
|
|
EP2555794A4
(en)
|
2010-04-05 |
2014-01-15 |
Univ Chicago |
COMPOSITIONS AND METHODS RELATING TO PROTEIN A (SPA) ANTIBODIES AS IMMUNE REACTION AMPLIFIERS
|
|
BR112013000097B1
(pt)
*
|
2010-07-02 |
2022-02-01 |
The University Of Chicago |
Polipeptídeo imunogênico isolado, composição imunogênica e seu uso
|